Results 11 to 20 of about 680,918 (208)

Chemotherapy for Small Cell Lung Carcinoma [PDF]

CA: A Cancer Journal for Clinicians, 1979
openaire   +4 more sources

Combined small-cell lung carcinoma

OncoTargets and Therapy, 2018
Currently, studies assessing combined small-cell lung carcinoma (C-SCLC) are relatively scarce and limited. Indeed the clinicopathological features, treatment, and prognosis of patients with C-SCLC have not been fully determined. The incidence of C-SCLC ranges from 5%-28% in different studies, which is related to the specimen types used.
Jing Qin, Hongyang Lu
openaire   +4 more sources

A rare case of pulmonary endobronchial spindle cell carcinoma with liver metastasis along with concurrent cutaneous neurofibroma

The Journal of Association of Chest Physicians, 2023
Spindle cell carcinoma is one of the histological variants of pulmonary sarcomatoid carcinoma. It is a rare, poorly differentiated, highly malignant, and rapidly growing non-small cell carcinoma of the lung.
Pratap Upadhya, C. Sivaselvi, Christie George Joseph, Bheemanathi Hanuman Srinivas   +3 more
doaj   +1 more source

The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung [PDF]

, 2018
Introduction: Because small-cell lung carcinomas (SCLC) are seldom resected, human materials for study are limited. Thus, genetically engineered mouse models (GEMMs) for SCLC and other high-grade lung neuroendocrine (NE) carcinomas are crucial for ...
Berns, Anton, Brambilla, Elisabeth, Farago, Anna F., Gazdar, Adi F., Jacks, Tyler E., Johnson, Jane E., Linnoila, R. Ilona, MacPherson, David, McFadden, David Glenn, Sage, Julien, Savage, Trisha K., Travis, William D.   +11 more
core   +1 more source

A Nonresponding Small Cell Lung Carcinoma [PDF]

Journal of Thoracic Oncology, 2009
We present a case with limited disease small cell lung carcinoma with persisting disease and a troublesome syndrome of inappropriate antidiuretic hormone, despite concurrent chemoradiotherapy and second-line chemotherapy. To gain local control, a lobectomy was performed.
Pronk, N.B., Pohnan, A.J., Sterk, L., Osterhuis, J.W.A., Smit, E.F.   +4 more
openaire   +3 more sources

Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

Cancer Management and Research, 2023
Zhisheng Liu,1,* Junling Zhang,2,* Yunjie Ge,3 Mengli Huang,2 Ye Wang1 1Department of General Surgery, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, Shandong People’s Republic
Liu Z, Zhang J, Ge Y, Huang M, Wang Y
doaj  

Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report

Cancer Management and Research, 2023
Diming Wang,1,* Wei Ye,2,* Dongmei Chen,1 Qingming Shi,1 Dongchun Ma3 1Department of Oncology, Anhui Chest Hospital, Hefei, 230022, People’s Republic of China; 2Department of Pathology, Anhui Chest Hospital, Hefei, 230022, People’s Republic of ...
Wang D, Ye W, Chen D, Shi Q, Ma D
doaj  

Characteristics of Peripheral versus Central Lung Cancer Since 2000 [PDF]

Kosin Medical Journal, 2014
Objectives The aim of this study was to explore the changes of bronchoscopic features according to epidemiologic change of lung cancer. Methods We performed a retrospective review of the clinical characteristics of 1,139 lung cancer patient who underwent
So Young Ock, Tae Won Jang, You Jin Han, Go Eun Yeo, Eun Jung Kim, Won Hyoung Lee, Nam Kyu Kim   +6 more
doaj   +1 more source

the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma

مجلة كلية الطب, 2023
Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet, Hadeel Abdulelah Karbel KERBEL, Ali Salih Baay Baay, Muhammed Whaeeb Salman Al-Obaidy   +3 more
doaj   +1 more source

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature

Lung India, 2018
A subset of non-small cell lung carcinoma (NSCC) harbor active mutations of epidermal growth factor receptor (EGFR). In these, EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as the first-line treatment.
Monalisa Hui, Shantveer G Uppin, Bala Joseph Stalin, G Sadashivudu   +3 more
doaj   +1 more source